Article Details

AbbVie cancer drug fails in phase 3 combination trial - MedWatch

Retrieved on: 2025-06-17 15:25:45

Tags for this article:

Click the tags to see associated articles and topics

AbbVie cancer drug fails in phase 3 combination trial - MedWatch. View article details on hiswai:

Excerpt

AbbVie developed Venclexta in collaboration with Roche. It is marketed in the US by Abbie and Genentech, part of the Roche Group, while AbbVie is ...

Article found on: medwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo